Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2001&ndash
by from Morbidity and Mortality Weekly Report (MMWR) on (#5WZEQ)
This report describes the treatment of Chagas disease using nifurtimox.